• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

IPILIMUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

TH17 CELLS LISTERIA MONOCYTOGENES STREPTOCOCCUS PNEUMONIAE FOXP3 CANDIDA ALBICANS ERBB-2 PORPHYROMONAS GINGIVALIS AUTOPHAGY ALZHEIMER'S DISEASE APOPTOTIC PROCESS CELL DIFFERENTIATION BREAST CANCER IL17A RECEPTOR CELL DIVISION CELL PROLIFERATION IFNG NEURODEGENERATIVE DISORDERS CD4 STAPHYLOCOCCUS AUREUS METFORMIN TP53 PARKINSON DISEASE HELICOBACTER PYLORI CANCER PSEUDOMONAS AERUGINOSA DOXORUBICIN REMICADE RHEUMATOID ARTHRITIS IMMUNE RESPONSE INSULIN CASP3 IL23A IL6 AGING ESCHERICHIA COLI 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DEATH CLOSTRIDIUM DIFFICILE INFLAMMATION SOD1 ANGIOGENESIS DIABETES MELLITUS TNF CTLA4

© 2019 Biovista Vizit All Rights Reserved.